4.8 Article

A DNA-Based Nanocarrier for Efficient Gene Delivery and Combined Cancer Therapy

期刊

NANO LETTERS
卷 18, 期 6, 页码 3328-3334

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acs.nanolett.7b04812

关键词

Self-assembly; DNA nanotechnology; drug delivery; gene therapy; cancer therapy

资金

  1. National Natural Science Foundation of China [21573051, 21708004, 51761145044]
  2. Science Fund for Creative Research Groups of the National Natural Science Foundation of China [21721002]
  3. National Basic Research Program of China [2016YFA0201601]
  4. Beijing Municipal Science & Technology Commission [Z161100000116036]
  5. Key Research Program of Frontier Sciences, CAS [QYZDB-SSW-SLH029]
  6. CAS Interdisciplinary Innovation Team
  7. K. C. Wong Education Foundation

向作者/读者索取更多资源

The efficient delivery of a therapeutic gene into target tissues has remained a major obstacle in realizing a viable gene-based medicine. Herein, we introduce a facile and universal strategy to construct a DNA nanostructure-based codelivery system containing a linear tumor therapeutic gene (p53) and a chemotherapeutic drug (doxorubicin, DOX) for combined therapy of multidrug resistant tumor (MCF-7R). This novel codelivery system, which is structurally similar to a kite, is rationally designed to contain multiple functional groups for the targeted delivery and controlled release of the therapeutic cargoes. The self-assembled DNA nanokite achieves efficient gene delivery and exhibits effective inhibition of tumor growth in vitro and in vivo without apparent systemic toxicity. These structurally and chemically well-defined codelivery nanovectors provide a new platform for the development of gene therapeutics for not only cancer but also a wide range of diseases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据